Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Alvarez

Showing results (551-560 of 644) with videos related to

Pageof 65
Sort By:
Gynecologic Oncology|April 1, 1997
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancerJohn G Page, Baohong Tian, Karen Schweikart, et al.
Nature Communications|January 14, 2025
Intelligent in-cell electrophysiology: Reconstructing intracellular action potentials using a physics-informed deep learning model trained on nanoelectrode array recordingsKeivan Rahmani, Yang Yang, Ethan Paul Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cellsAnna Kanerva, Galina V Mikheeva, Victor Krasnykh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2011
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancerAdam D Steg, Ashwini A Katre, Blake Goodman, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Cancer Research|February 19, 2013
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunityTae Heung Kang, Chih-Ping Mao, Sung Yong Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccinationChih-Wen Tseng, Chien-Fu Hung, Ronald D Alvarez, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 10, 2002
Inhalation of a harmless antigen (ovalbumin) elicits immune activation but divergent immunoglobulin and cytokine activities in miceF K Swirski, B U Gajewska, D Alvarez, et al.
American Journal of Obstetrics and Gynecology|May 29, 2004
Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient studyWarner K Huh, Ramon M Cestero, Francisco A Garcia, et al.
Pageof 65

Showing results (551-560 of 644) with videos related to

Sort By:
Pageof 65
Gynecologic Oncology|April 1, 1997
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II studyR D Alvarez, E E Partridge, M B Khazaeli, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancerJohn G Page, Baohong Tian, Karen Schweikart, et al.
Nature Communications|January 14, 2025
Intelligent in-cell electrophysiology: Reconstructing intracellular action potentials using a physics-informed deep learning model trained on nanoelectrode array recordingsKeivan Rahmani, Yang Yang, Ethan Paul Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cellsAnna Kanerva, Galina V Mikheeva, Victor Krasnykh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2011
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancerAdam D Steg, Ashwini A Katre, Blake Goodman, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Cancer Research|February 19, 2013
Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunityTae Heung Kang, Chih-Ping Mao, Sung Yong Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccinationChih-Wen Tseng, Chien-Fu Hung, Ronald D Alvarez, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 10, 2002
Inhalation of a harmless antigen (ovalbumin) elicits immune activation but divergent immunoglobulin and cytokine activities in miceF K Swirski, B U Gajewska, D Alvarez, et al.
American Journal of Obstetrics and Gynecology|May 29, 2004
Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient studyWarner K Huh, Ramon M Cestero, Francisco A Garcia, et al.
Pageof 65